Cephalon Sues To Block Travelers' $17M Actiq Coverage Claim

Law360, New York (July 13, 2012, 9:58 PM EDT) -- Teva Pharmaceutical Industries Ltd. unit Cephalon Inc. on Thursday hit the Travelers Companies Inc. with a suit to block the insurer from trying to recoup some $17 million it claims it paid to cover prescriptions for off-label uses of cancer pain medication Actiq.

In a complaint filed in New York federal court, Cephalon said Travelers was seeking the payment even though Cephalon stopped actively promoting the drug six years ago, and despite a 2008 settlement Cephalon entered into with federal authorities in 2008.

Cephalon is seeking...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.